Ramtin Agah
Chief Medical Officer at RenovoRx, Inc. (RNXT)
Purchase track record
Market-like. Based on 2 purchases with a full 90 days of price history.
50
Avg. 90-day return+2.0%
vs. S&P 500+0.1%
Beat the market50%
Paper profit on buys+$26K
Total bought / sold$56K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 22SEC | RNXTRenovoRx, Inc. | Buy | 10,000798,460 held (+1%) | $1.00 | $10K | +28.0% |
| Jan 5SEC | RNXTRenovoRx, Inc. | Buy | 9,795788,460 held (+1%) | $0.86 | $8K | +48.8% |
| Jan 2SEC | RNXTRenovoRx, Inc. | Buy | 205778,665 held (+0%) | $0.83 | $170 | +54.2% |
| Dec 17SEC | RNXTRenovoRx, Inc. | Buy | 12,000778,460 held (+2%) | $0.85 | $10K | +50.6% |
| Dec 8SEC | RNXTRenovoRx, Inc. | Buy | 10,000766,460 held (+1%) | $0.96 | $10K | +33.3% |
| Nov 24SEC | RNXTRenovoRx, Inc. | Buy | 10,000744,460 held (+1%) | $0.80 | $8K | +60.0% |
| Nov 24SEC | RNXTRenovoRx, Inc. | Buy | 12,000756,460 held (+2%) | $0.80 | $10K | +60.0% |
- Buy
Chief Medical Officer Ramtin Agah bought $10K of RNXT at $0.85 — largest purchase by this insider in our records.
- Buy
Chief Medical Officer Ramtin Agah bought $8K of RNXT at $0.80 — first open-market purchase in our records.
- Buy
Chief Medical Officer Ramtin Agah bought $10K of RNXT at $0.80 — largest purchase by this insider in our records.